Pharma & Bio
Technology
[Bio Spotlight] GC WellBeing Soars on Phase 3 Clinical Trial Results for Fat-Dissolving Injection… JW SHINYAK CORPORATION Also Rises
On the 3rd, the domestic pharmaceutical and biotech sector saw notable volatility in stocks linked to growth themes such as obesity, medical aesthetics, hair loss, and immuno-oncology platforms. On th…
- 2026-09-05 08:01:04
- Kim Seung-kwon
Technology
Ildong Pharma Jumps 14% on Patent Ruling, Renewed Hopes for Obesity Drug Licensing [K-Bio Pulse]
Ildong Pharmaceutical stock trend on August 10. (Image: MP Doctor)
On September 2, Ildong Pharmaceutical emerged as one of the strongest performers among South Korean pharmaceutical and biotech st…
- 2026-09-04 08:32:03
- Minji Son
Technology
ILDONG PHARM Jumps 14%… Patent Ruling Revives Hopes for Weight-Loss Drug [Bio Spotlight]
Il Dong Pharmaceutical Stock Price Trend. (Source: KG Zeroin MP Doctor)
On the 2nd, ILDONG PHARM(249420)surged in the domestic pharmaceutical and biotech market. This is believed to be due to buyi…
- 2026-09-04 08:32:01
- Minji Son
Lifestyle
Genome&Company’s GENA-120: Expectations Rise for Technology Transfer Following Deal with China’s Cestone
Genome&Company(314130)is aiming for its third technology export deal, led by its next-generation antibody-drug conjugate (ADC) candidate, “GENA-120.” Although GENA-120 is still in the early clinical s…
- 2026-09-04 08:21:02
- Kim Jinsoo
Lifestyle
[Exclusive] Remedy Confirms Supply of Portable X-ray and Ultrasound Devices to the U.S. AMA… "AI-Powered Remote Diagnosis Breaks into the U.S. Market"
#Remedy, a company specializing in ultra-compact X-ray technology, has secured a contract to supply its equipment to the American Medical Administrators (AMA), a U.S. healthcare services group, and is…
- 2026-09-04 08:06:03
- YU JIN-HEE
Technology
Yoon Ji-hyun, CEO of Willog: "Sensor Data Is the New Language of Insurance; It Will Transform the Pharmaceutical Cold Chain"
The pharmaceutical cold chain (low-temperature distribution system) logistics process has long been referred to as a “black box.” In the pharmaceutical and biotech logistics sector, there have been re…
- 2026-09-03 11:02:02
- Kim Seung-kwon
Technology
'500% Surge': Wall Street Is Obsessed with This Hair Loss Treatment… "The Next Gold Mine After Obesity Drugs" [Bio Spotlight]
Following obesity treatments, hair loss treatments are emerging as a new investment opportunity in global stock markets. In South Korea as well, related stocks have surged on expectations that hair lo…
- 2026-09-03 08:52:03
- NA EUN-KYUNG
Technology
Hair-Loss Stocks Rally, Peptron Falls as Lilly Deadline Nears [K-Bio Pulse]
Hair-loss treatments are emerging as a new investment theme in global stock markets following the obesity drug boom. In South Korea, expectations for expanded national health insurance coverage have s…
- 2026-09-03 08:52:03
- NA EUN-KYUNG
Business·Industry
[Noul Co., Ltd. Deep Dive ①] The Story Behind the 21.2 Billion Won Order Backlog… Cumulative Deliveries at 19%—Not Confirmed Revenue
Noul Co., Ltd.(376930), a company specializing in AI-based diagnostic platforms, had an order backlog of 21.2 billion won at the end of the first half of this year, but the amount actually delivered t…
- 2026-09-03 08:52:02
- KIM SAE-MI
Technology
1 Trillion Yen Botulinum Toxin Market... Daewoong and Medytox Race to Secure Official Approval
#Daewoong Pharmaceutical has begun the process of seeking formal approval for its botulinum toxin “Nabota” (DWP450) in the Japanese market. Given Japan’s regulatory framework, which permits the use of…
- 2026-09-03 08:07:02
- KIM SUNG-JIN
PHARM EDAILY
Shorts